TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
LBRX

LB Pharmaceuticals Inc

Healthcare · Biotechnology

37.00$ -0.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LBRX
Line item Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – – -42.6% +0.0% +1,566.4% -2.4% +25.7% -8.1%
– – – – -48.8% +0.0% +2,040.6% -2.5% +26.1% -8.7%
– – – – -38.1% +0.0% +1,796.3% -7.3% +28.2% -11.7%
– – – – – +0.0% +2,110.7% -6.1% +23.9% -10.4%
– – – – -93.1% +1,289.3% -91.5% +10.4% +27.2% +98.4%
– – – – -51.8% +0.0% +70.2% +12.0% +46.5% +116.1%
– – – – – +0.0% +0.0% +0.0% +0.0% +15.6%
– – – – -72.6% +0.0% +307.9% -17.9% +234.7% -51.0%
– – – – – -1,100.1% – -2.9% +25.7% -12.2%
– – – – – – – – – –
– 0.0% +534.0% +0.0% -98.9% +0.0% +9,947.7% +0.0% +11.6% +6.7%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?